Trials / Sponsors / Heronova Pharmaceuticals
Heronova Pharmaceuticals
Industry · 6 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study of DC6001 Tablet in Healthy Chinese Adult Subjects Stargardt Disease | Phase 1 | 2026-01-01 |
| Recruiting | A Study of DC50292A Tablet in Patients With MTAP-deleted Advanced or Metastatic Solid Tumors Solid Tumor Malignancies | Phase 1 | 2025-06-30 |
| Recruiting | A Study of DC05F01 in Chinese Patients with Recurrent/Refractory Ovarian Cancer and Other Advanced Solid Tumor Solid Tumors, Ovarian Cancer, Small Cell Lung Cancer | Phase 1 / Phase 2 | 2024-09-11 |
| Completed | Relative Bioavailability Study of CX2101A for the Treatment of COVID-19 COVID-19, Coronavirus Infection | Phase 1 | 2024-03-21 |
| Completed | A Study of CX2101A Enteric-Coated Tablets in Healthy Chinese Adult Subjects COVID-19, Coronavirus Pneumonia | Phase 1 | 2022-12-26 |
| Completed | A Study of DC05F01 in Chinese Patients with Advanced or Metastatic Solid Tumors Solid Tumors | Phase 1 | 2022-07-08 |